Cost of treating peripheral neuropathic pain with pregabalin or gabapentin at therapeutic doses in routine practice.

CONCLUSION: At therapeutic doses, pregabalin was found to have lower healthcare and non-healthcare costs than gabapentin in routine practice. PMID: 29754518 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research